British consumer healthcare group Haleon on Thursday said 2025 revenue and profit growth would be weighted to the second half ...

Haleon posted £11.23B in FY24 revenue, with 5% organic growth. 2025 guidance expects 4-6% organic growth, with profit gains ...

UK's Haleon reported annual profit in line with market expectations on Thursday, as the Sensodyne toothpaste and Advil ...

Haleon projects a gradual revenue and profit ... The company, which makes Sensodyne toothpaste, ENO antacids and Centrum multivitamins, projected organic revenue would grow between 4 per cent ...

伦敦 - 全球消费者保健公司Haleon PLC（LSE/NYSE: HLN）今日宣布其董事会成员发生变动。随着辉瑞制药公司在Haleon的持股比例降至10%以下，代表辉瑞制药的非执行董事Bryan Supran已即刻辞去董事会职务。

HALEON PLC (LON:HLN) shares slid 3% in London on Thursday after the Sensodyne toothpaste maker said its revenue growth for 2025 would be weighted toward the second half of the year.

Sensodyne-maker Haleon’s annual profits rose in line with expectations last year as it got a boost in demand for its oral ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Haleon, which focuses on over-the-counter medicines, oral health, and vitamins, minerals and supplements, generated £1.9bn in ...

The maker of Panadol, Sensodyne toothpaste and Centrum vitamins posted a higher pretax profit for 2024 despite lower revenue.